Skip to main content
Top

Molecular Imaging and Biology

Issue 4/2025

Content (16 Articles)

Go Fish! Hepatic Uptake of Clinical Hepatospecific Gadolinium-Based MRI Contrast Agents in Zebrafish is Similar to Humans

  • Open Access
  • Brief Article

Josie A. Shapiro, Tapas Bhattacharyya, Lauren A. Squire, Christiane L. Mallett, Jeremy M.-L. Hix, Legend E. Kenney, Aitor Aguirre, Erik M. Shapiro

MIB guides: [89Zr]Zr-DFO-trastuzumab and [64Cu]Cu-NOTA-Trastuzumab for Preclinical Cancer Imaging

Cristina Simó, Alexander C. Vanover, E. Carmen Azevedo, Patrícia M. R. Pereira

Preclinical Evaluation of a Near-Infrared Labelled Antibody Targeting the Tumour Associated Xenoantigen N-Glycolyl-Neuraminic Acid GM3 Ganglioside

  • Open Access
  • Research Article

Kris Barreto, Wendy Bernhard, Darien Toledo, Kimberly Jett, Angel Casaco, Kalet León, C. Ronald Geyer

Diagnostic Value of [18F]-FDG and [68 Ga]-FAPI-04 PET/MRI for Lymph Node Metastasis in Papillary Thyroid Cancer

Tingting Han, Zhiyong Quan, Hongliang Wei, Mingru Zhang, Jiajun Ye, Guiyu Li, Junling Wang, Taoqi Ma, Jing Wang, Fei Kang

Preclinical Evaluation of Novel SGLT2-Targeted Near-Infrared Optical Imaging Agent for Early-Stage Pulmonary Adenocarcinoma

Katherine Ortmeyer Welch, Kelly Anne McGovern, Lydia Chen, Ryan Krouse, Kevin Guo, Jeffrey Huang, Michael Brown, Jake Mlakar, Venu Bandi, David Holt, Paul Zhang, Sunil Singhal

Evaluation of 177Lu-Labeled Lipiodol as a Targeted Radionuclide Therapy for Hepatocellular Carcinoma in a Preclinical Xenograft Model

Yumiko Kono, Keita Utsunomiya, Takahiro Shiraishi, Naoki Kan, Ichiro Shiojima, Kaoru Maruyama, Noboru Tanigawa

One-step Radiosynthesis and Preclinical Evaluation of Molecular Tracer [18F]FEtO-CHC Targeting Monocarboxylate Transporters for PET Imaging in Tumor-bearing Mice

Dongmei Shi, Ling Liu, Di Zhang, Yuzhou Zheng, Wenhao Hu, Ping Wu, Xinzhong Hao, Haiyan Liu, Jie Gao, Jianguo Li, Zhifang Wu, Sijin Li, Hongliang Wang

[68Ga]Ga-PSMA-11 PET/CT and [18F]Fluorocholine PET/CT in Assessment and Clinical Decision Making of Recurrent Prostate Cancer: A Prospective Crossover Trial

Mohsen Beheshti, Malihe Shahbazi-Akbari, Marcus Hacker, Wolfgang Loidl, Werner Langsteger

Targeted Radionuclide Therapy Using a Lutetium-177 Labeled Human Anti-CD133 Antibody

Kevin Wyszatko, Nancy Janzen, Napoleon Law, Manuela Ventura, Teesha Komal, Neil Savage, Chitra Venugopal, Jacek M. Kwiecien, Sheila K. Singh, Saman Sadeghi

Local Infusing Antiplatelet Microspheres to Prevent Thrombosis Post-PCI: a Feasibility Study in Rabbit Aorta

Yueyou Peng, Kunkun Liu, Wei Tian, Tianfeng Shi, Qixiong Lin, Yanmei Tian, Rongrong Li, Yanfeng Meng

Long-term Local Control Following CEA-targeted Fluorescence-guided Surgery in Patients With Locally Advanced and Recurrent Rectal Cancer

Mats I. Warmerdam, Davy M. J. Creemers, Miranda Kusters, Koen C. M. J. Peeters, Fabian A. Holman, J. Sven D. Mieog, Francoise Cailler, Pim J. W. A. Burger, Jacobus Burggraaf, Harm J. T. Rutten, Cornelis Verhoef, Alexander L. Vahrmeijer, Denise E. Hilling

Positive Protective Effects of Sigma-1 Receptor Stimulation with Fluvoxamine after Myocardial Ischemia and Reperfusion in Rats

Xue Zhang, Hiroshi Wakabayashi, Hiroshi Mori, Tomo Hiromasa, Zhuoqing Chen, Takashi Kozaka, Kazuma Ogawa, Seigo Kinuya, Junichi Taki

Poor Diagnostic Performance of the Melanin-Binding Tracer [18 F]MEL050 in Human Melanoma Indicates Biological Heterogeneity

Robert E. Ware, Damien Kee, Peter Roselt, Ivan Greguric, Andrew Katsifis, Thomas Bourdier, Wayne Noonan, William Murray, Catherine Mitchell, Marnie Downes, Mark Shackleton, Grant A. McArthur, Rodney J. Hicks

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

0.5 AMA PRA Category 1 Credit(s)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Learn more

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Learn more
Image Credits
Alzheimer’s disease in the biomarker era: preparing the multidisciplinary care team/© Springer Healthcare IME, Navigating neuroimaging in Alzheimer’s care: Practical applications and strategies for integration/© Springer Health+ IME